REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients

REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients

roswellpark

3 years
850 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Philip McCarthy, MD, Director of the Blood and Marrow Transplant Center at Roswell Park Cancer Institute in Buffalo, NY, shares benefits of lenalidomide maintenance therapy for multiple myeloma patients.
Up Next Autoplay